Home/Contractors/Modernatx, INC.

Federal Contractor Profile

Modernatx, INC.

Federal contracting record: $10B obligated across 6 awards from 3 agencies, FY 2016–2025.

$10B
Total Obligated
6
Award Records
3
Agencies Served
4
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

UEI (Unique Entity Identifier)

WJYNZ8AK2D47

CAGE Code

6RP85

Parent Organization

Modernatx, INC.

Address

200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 021393578

First Federal Award

Sep 1, 2016

Most Recent Award

Apr 10, 2025

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Defense

    3 awards · 81.8% of total

    $8.2B

  • Department of Health and Human Services

    2 awards · 18.2% of total

    $1.8B

  • Department of Veterans Affairs

    1 awards · 0.0% of total

    $12K

Top NAICS Activity

  • 325412

    PHARMACEUTICAL PREPARATION MANUFACTURING

    3 awards

    $8.2B

  • 325414

    BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

    1 awards

    $1.8B

  • 541711

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

    1 awards

    $73M

  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    1 awards

    $0

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Sep 21, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$48M
Sep 14, 2023Department of Veterans Affairs250-NETWORK CONTRACT OFFICE 10 (36C250)325412COVID VACCINES$12K
May 1, 2023Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$508K
Aug 16, 2022Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$17M
Jun 30, 2022Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$4.8M
Apr 14, 2022Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$11M
Mar 28, 2022Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$26M
Feb 23, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$308M
Jan 21, 2022Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$203K
Jun 15, 2021Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$3.3B
Jun 10, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$144M
Jun 4, 2021Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$4.0M
Mar 16, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$236M
Mar 11, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$63M
Feb 11, 2021Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$1.6B
Dec 11, 2020Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$2.0B
Aug 11, 2020Department of DefenseW6QK ACC-APG NATICK325412100M SARS-COV-2 MRNA-1273 VACCINE DOSES$1.2B
Jul 25, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$472M
Jun 25, 2020Department of DefenseW6QK ACC-APG NATICK325412SARS-COV-2 MRNA-1273 VACCINE$540M
May 20, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$53M
Apr 3, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT$430M
Apr 19, 2018Department of DefenseNAVAL MEDICAL RESEARCH CENTER541714IGF::OT::IGF MRNA PRODUCTION (4MG)$83K
Mar 20, 2017Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF$65M
Sep 16, 2016Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF$44M
Sep 1, 2016Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF$8.2M

Related Contractors

Other companies active in NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING.

Mckesson Corporation

$36B

Merck Sharp & Dohme LLC

$8.7B

Pfizer INC

$5.9B

Sanofi Vaccines US INC.

$2.8B

Glaxosmithkline, LLC

$2.2B

Bavarian Nordic A/s

$492M

Moderna US, INC.

$452M

Emergent Biosolutions Canada INC

$424M

Track Modernatx, INC. Recompetes Before They Post

Mindy monitors Modernatx, INC.'s active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts